The average one-year price target for CapsoVision (NasdaqCM:CV) has been revised to $6.12 / share. This is an increase of 20.00% from the prior estimate of $5.10 dated November 7, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $5.05 to a high of $7.35 / share. The average price target represents an increase of 19.53% from the latest reported closing price of $5.12 / share.
What are Other Shareholders Doing?
Geode Capital Management holds 115K shares representing 0.25% ownership of the company.
Northern Trust holds 43K shares representing 0.09% ownership of the company.
Citadel Advisors holds 24K shares representing 0.05% ownership of the company.
Charles Schwab Investment Management holds 14K shares representing 0.03% ownership of the company.
Marshall Wace, Llp holds 13K shares representing 0.03% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
